课题基金 / 基金详情

项目摘要

项目成果

JENNETTA W HAMMOND的其他基金

相似基金

相关文献

中文摘要
翻译
补体通过神经胶质细胞促进突触修剪,以完善神经回路 发育,但也可能在病理性地破坏成熟的、必要的突触 神经炎。免疫功能障碍和突触修剪的不平衡 与自闭症谱系障碍(ASD)有关,最近的研究表明,调节失调 的补语可以连用。在此应用程序中要检验的中心假设是 Sez6基因家族的成员已被确认为ASD易感基因, 新颖的,突触定位的,补充了防止异常所需的调节器 与ASD相关的突触修剪。在目标1中,我们将定义补充性调节属性 使用标准补体试验检测Sez6、Sez6L和Sez6L2的同源性。然后我们将进行调查 Sez6家族能否在体外阻止补体在突触沉积。在目标2中,我们 将使用16p11.2缺失的自闭症小鼠模型,在该模型中,Sez6L2与其他 基因,以确定增强的补体依赖突触修剪是否发生在 视觉系统中的视网膜原基突触。还将按顺序测试Sez6L2基因敲除 验证发现并确认SezL2对16p11.2表型的重要性。在……里面 总而言之,我们希望从这些实验中获得的数据将推动我们对 Sez6蛋白在补体介导突触机制中的作用 在发育过程中的消除可能解释了该基因家族如何导致易感性 致ASD。
英文摘要
Complement promotes synaptic pruning by glia in order to refine neural circuits during development, but may also pathologically destroy mature, essential synapses in the context of neuroinflammation. Immune dysfunction and an imbalance in synaptic pruning have been implicated in autism spectrum disorder (ASD), and recent studies suggest that dysregulation of complement may be connected. The central hypothesis to be tested in this application is that the Sez6 gene family, whose members have been identified as ASD susceptibility genes, are novel, synaptically localized, complement regulators that are required to prevent aberrant synaptic pruning related to ASD. In Aim 1, we will define the complement regulatory properties of Sez6, Sez6L, and Sez6L2 using standard complement assays. We will then investigate whether the Sez6 family can prevent complement deposition at synapses in vitro. In Aim 2, we will use the 16p11.2 deletion mouse model of autism, in which Sez6L2 is lost along with other genes, to determine if enhanced complement dependent synapse pruning occurs at retinogeniculate synapses in the visual system. A Sez6L2 knockout will also be tested in order to validate findings and confirm the importance of SezL2 to the 16p11.2 phenotype. In aggregate, we expect the data obtained from these experiments to advance our understanding of the role of Sez6 proteins in mechanisms underlying complement-mediated synapse elimination during development that may explain how this gene family contributes susceptibility to ASD.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2021.607641
发表时间: 2021
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Qiu WQ, Luo S, Ma SA, Saminathan P, Li H, Gunnersen JM, Gelbard HA, Hammond JW]
通讯作者: Hammond JW
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
  • 批准号:
    10740682
  • 项目类别:
  • 资助金额:
    $8.88万
  • 财政年份:
    2023
  • 负责人:
    JENNETTA W HAMMOND
  • 依托单位:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
  • 批准号:
    10526475
  • 项目类别:
  • 资助金额:
    $42.35万
  • 财政年份:
    2022
  • 负责人:
    JENNETTA W HAMMOND
  • 依托单位:
Sez6 proteins as protection factors in complement-mediated synaptic pruning
  • 批准号:
    10179969
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2021
  • 负责人:
    JENNETTA W HAMMOND
  • 依托单位:
Sez6 proteins as protection factors in complement-mediated synaptic pruning
  • 批准号:
    10372193
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2021
  • 负责人:
    JENNETTA W HAMMOND
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: